Literature DB >> 24713280

U.S. healthcare providers' experience with Lyme and other tick-borne diseases.

Meghan E Brett1, Alison F Hinckley2, Emily C Zielinski-Gutierrez1, Paul S Mead1.   

Abstract

Surveillance indicates that tick-borne diseases are a common problem in the United States. Nevertheless, little is known regarding the experience or management practices of healthcare providers who treat these conditions. The purpose of the present study was to characterize the frequency of tick-borne diseases in clinical practice and the knowledge of healthcare providers regarding their management. Four questions about tick-borne diseases were added to the 2009 Docstyles survey, a nationally representative survey of >2000 U.S. healthcare providers. Topics included diseases encountered, management of patients with early Lyme disease (LD), provision of tick-bite prophylaxis, and sources of information on tick-borne diseases. Overall, 51.3% of practitioners had treated at least one patient for a tick-borne illness in the previous year. Among these, 75.1% had treated one type of disease, 19.0% two types of disease, and 5.9% three or more diseases. LD was encountered by 936 (46.8%) providers; Rocky Mountain spotted fever was encountered by 184 (9.2%) providers. Given a scenario involving early LD, 89% of providers would prescribe antibiotics at the first visit, with or without ordering a blood test. Tick-bite prophylaxis was prescribed by 31.0% of all practitioners, including 41.1% in high-LD-incidence states and 26.0% in low-incidence states. Tick-borne diseases are encountered frequently in clinical practice. Most providers would treat early LD promptly, suggesting they are knowledgeable regarding the limitations of laboratory testing in this setting. Conversely, providers in low-LD-incidence states frequently prescribe tick-bite prophylaxis, suggesting a need for education to reduce potential misdiagnosis and overtreatment. Published by Elsevier GmbH.

Entities:  

Keywords:  Lyme disease; Prophylaxis; Provider knowledge; Tick-borne disease; Treatment

Mesh:

Substances:

Year:  2014        PMID: 24713280      PMCID: PMC4625905          DOI: 10.1016/j.ttbdis.2014.01.008

Source DB:  PubMed          Journal:  Ticks Tick Borne Dis        ISSN: 1877-959X            Impact factor:   3.744


  24 in total

1.  Diagnosis, treatment, and prognosis of erythema migrans and Lyme arthritis.

Authors:  Henry M Feder; Micha Abeles; Megan Bernstein; Diane Whitaker-Worth; Jane M Grant-Kels
Journal:  Clin Dermatol       Date:  2006 Nov-Dec       Impact factor: 3.541

2.  Laboratory evaluation in the diagnosis of Lyme disease.

Authors:  P Tugwell; D T Dennis; A Weinstein; G Wells; B Shea; G Nichol; R Hayward; R Lightfoot; P Baker; A C Steere
Journal:  Ann Intern Med       Date:  1997-12-15       Impact factor: 25.391

3.  Prospective clinical evaluation of patients from Missouri and New York with erythema migrans-like skin lesions.

Authors:  Gary P Wormser; Edwin Masters; John Nowakowski; Donna McKenna; Diane Holmgren; Katherine Ma; Lauren Ihde; L Frank Cavaliere; Robert B Nadelman
Journal:  Clin Infect Dis       Date:  2005-08-31       Impact factor: 9.079

4.  The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.

Authors:  Gary P Wormser; Raymond J Dattwyler; Eugene D Shapiro; John J Halperin; Allen C Steere; Mark S Klempner; Peter J Krause; Johan S Bakken; Franc Strle; Gerold Stanek; Linda Bockenstedt; Durland Fish; J Stephen Dumler; Robert B Nadelman
Journal:  Clin Infect Dis       Date:  2006-10-02       Impact factor: 9.079

5.  The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study.

Authors:  M C Reid; R T Schoen; J Evans; J C Rosenberg; R I Horwitz
Journal:  Ann Intern Med       Date:  1998-03-01       Impact factor: 25.391

6.  Tick bites and Lyme disease in an endemic setting: problematic use of serologic testing and prophylactic antibiotic therapy.

Authors:  A D Fix; G T Strickland; J Grant
Journal:  JAMA       Date:  1998-01-21       Impact factor: 56.272

Review 7.  Diagnosis of lyme borreliosis.

Authors:  Maria E Aguero-Rosenfeld; Guiqing Wang; Ira Schwartz; Gary P Wormser
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

8.  Antibiotic therapy for Lyme disease in Maryland.

Authors:  G T Strickland; I Caisley; M Woubeshet; E Israel
Journal:  Public Health Rep       Date:  1994 Nov-Dec       Impact factor: 2.792

9.  Physician beliefs, attitudes, and approaches toward Lyme disease in an endemic area.

Authors:  S C Eppes; J D Klein; G M Caputo; C D Rose
Journal:  Clin Pediatr (Phila)       Date:  1994-03       Impact factor: 1.168

Review 10.  Misdiagnosis of erythema migrans.

Authors:  H M Feder; D L Whitaker
Journal:  Am J Med       Date:  1995-10       Impact factor: 4.965

View more
  8 in total

1.  Increasing Incidence of Ehrlichiosis in the United States: A Summary of National Surveillance of Ehrlichia chaffeensis and Ehrlichia ewingii Infections in the United States, 2008-2012.

Authors:  Kristen Nichols Heitman; F Scott Dahlgren; Naomi A Drexler; Robert F Massung; Casey Barton Behravesh
Journal:  Am J Trop Med Hyg       Date:  2015-11-30       Impact factor: 2.345

2.  Knowledge, attitudes, and practices of veterinary professionals towards ticks and tick-borne diseases in Illinois.

Authors:  Samantha D Crist; Heather Kopsco; Alexandria Miller; Peg Gronemeyer; Nohra Mateus-Pinilla; Rebecca L Smith
Journal:  One Health       Date:  2022-04-24

Review 3.  Current and Future Molecular Diagnostics of Tick-Borne Diseases in Cattle.

Authors:  Kathryn Garcia; Mina Weakley; Tram Do; Sheema Mir
Journal:  Vet Sci       Date:  2022-05-21

4.  Tick Bite Prophylaxis: Results From a 2012 Survey of Healthcare Providers.

Authors:  A E Perea; A F Hinckley; P S Mead
Journal:  Zoonoses Public Health       Date:  2014-09-22       Impact factor: 2.702

5.  Diagnosis, Treatment, and Prevention Practices for Lyme Disease by Clinicians, United States, 2013-2015.

Authors:  Alyssa R Beck; Grace E Marx; Alison F Hinckley
Journal:  Public Health Rep       Date:  2021-02-04       Impact factor: 3.117

6.  Model-based risk assessment and public health analysis to prevent Lyme disease.

Authors:  Nasser Sharareh; Nasim S Sabounchi; Amanda Roome; Rita Spathis; Ralph M Garruto
Journal:  R Soc Open Sci       Date:  2017-11-15       Impact factor: 2.963

7.  Protein and DNA Biosynthesis Demonstrated in Host Cell-Free Phagosomes Containing Anaplasma phagocytophilum or Ehrlichia chaffeensis in Axenic Media.

Authors:  Yuntao Zhang; Li Chen; Chandramouli Kondethimmanahalli; Huitao Liu; Roman R Ganta
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

Review 8.  Ixodes Immune Responses Against Lyme Disease Pathogens.

Authors:  Chrysoula Kitsou; Utpal Pal
Journal:  Front Cell Infect Microbiol       Date:  2018-05-29       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.